| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |